Target intelligence / Profile preview

FLICE-inhibitory protein (FLIP)

Target
FLIP
Molecular classification
Apoptosis regulator, Death effector domain-containing protein, Pseudo-caspase
01

Overview

FLICE-inhibitory protein (FLIP) is a key negative regulator of apoptosis, particularly the extrinsic pathway triggered by death receptors. It exists in multiple isoforms (c-FLIPL and c-FLIPS) and functions by interfering with the formation of the death-inducing signaling complex (DISC), preventing caspase-8 activation. c-FLIP overexpression is associated with resistance to apoptosis in cancer and other diseases, making it a potential therapeutic target. Viral homologues (v-FLIPs) are used by viruses to evade host immune responses.

Other names
Cellular FLICE-inhibitory proteinc-FLIPCASP8 and FADD-like apoptosis regulatorCFLARCASHCasperCLARPFLAMEI-FLICEMRITUsurpinv-FLIPs (viral homologues)
02

Mechanism of action

Inhibits apoptosis by interfering with the formation of the death-inducing signaling complex (DISC), preventing recruitment and activation of initiator caspases (mainly caspase-8). Acts as a dominant-negative inhibitor by blocking downstream signaling events.

03

Biological functions

Apoptosis inhibitionRegulation of extrinsic apoptotic pathwayT-cell proliferationHeart developmentNF-kappaB signaling modulationIRF3-mediated interferon response modulationImmune regulation
04

Disease associations

CancerAutoimmune diseasesNeurodegenerative diseasesMultiple sclerosisAlzheimer's diseaseDiabetes mellitusRheumatoid arthritisInfection (viral evasion)
05

Safety considerations

Targeting c-FLIP may have unintended consequences on immune function.Potential for off-target effects due to structural similarity with caspases.Dysregulation of c-FLIP can have diverse effects depending on cellular context.

Beyond the preview

Go deeper on FLICE-inhibitory protein (FLIP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on FLICE-inhibitory protein (FLIP).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call